StockData
FRNMNasdaqServices-Medical LaboratoriesFiscal year ends December 31

Freenome, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 15, 2026
$12.57+0.82 (+6.98%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
–

Freenome, Inc. revenue by segment

AnnualQuarterlyTTM

No segment breakdown reported

Freenome does not break out revenue by segment, region or product in the tagged data of its filings for this period type.